ArticleRevista panamericana de salud publica = Pan American journal of public health2026
From fragmentation to integration: Patient-reported access to cardiovascular care in Colombia's primary health system.
Article in Revista panamericana de salud publica = Pan American journal of public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Glycated hemoglobin (A1c) values and antidiabetic treatment deprescription in hospitalized nonagenarians with type 2 diabetes.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To assess patient-reported experiences of access to services along the Cardio-Cerebrovascular and Metabolic Comprehensive Healthcare Pathways (CVD-RIAS) among patients with hypertension and/or diabetes in two primary health care networks in Bogotá, highlighting achievements and identifying remaining challenges to integrated care. Methods: Cross-sectional descriptive analysis using baseline data from patients with confirmed hypertension and/or type 2 diabetes enrolled in CVD-RIAS. In-person surveys and linked clinical records were used to examine access experiences across consultations, tests, prescriptions, and medication delivery. Results were stratified by age, education, income, and Charlson Comorbidity Index. Results: Of 1 258 patients, 85.5% reported no access issues for hypertension or diabetes care. Most (80%) rated contact frequency positively; most contacted were general physicians and pharmacies. Most patients contacted at least one professional (99.6%), received diagnostic tests (88%,) and obtained some or all prescribed medications (97.3%). Sixty percent accessed specialists, mostly through the assigned network. Median specialist wait was two months, longer for high-risk and higher-income patients. Perceptions were split: 45% found wait times reasonable, 45% did not. Ratings of contact frequency, wait times, and access to referred services varied by sociodemographic characteristics. Overall, patient care pathways were aligned with milestones defined in CVD-RIAS. Conclusions: The CVD-RIAS model is achieving goals of expanding access to services, aligning care delivery with clinical risk, and fostering positive patient experiences. These findings reflect progress toward risk-based, integrated service delivery. Remaining gaps - incomplete medication supply and difficulties accessing referred services - underscore the need for efforts to enhance coordination and equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.